Free Trial

IDEAYA Biosciences (IDYA) News Today

IDEAYA Biosciences logo
$19.56 +0.14 (+0.72%)
Closing price 04:00 PM Eastern
Extended Trading
$19.55 -0.01 (-0.08%)
As of 04:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IDYA Latest News

IDEAYA Biosciences, Inc. stock logo
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Position Increased by Voloridge Investment Management LLC
Voloridge Investment Management LLC raised its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 50.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 286,759 shares of the compa
IDEAYA Biosciences, Inc. stock logo
Squarepoint Ops LLC Buys 33,088 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Squarepoint Ops LLC raised its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 22.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 178,892 shares of the company
IDEAYA Biosciences, Inc. stock logo
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Sold by Two Sigma Investments LP
Two Sigma Investments LP decreased its position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 15.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 423,774 shares of the company's stock after
IDEAYA Biosciences, Inc. stock logo
Neo Ivy Capital Management Makes New Investment in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Neo Ivy Capital Management acquired a new stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 130,806 shares of the company's stock, valued at approx
IDEAYA Biosciences, Inc. stock logo
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the fourteen research firms that are presently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating, eleven have
IDEAYA Biosciences, Inc. stock logo
JPMorgan Chase & Co. Issues Positive Forecast for IDEAYA Biosciences (NASDAQ:IDYA) Stock Price
JPMorgan Chase & Co. lifted their target price on IDEAYA Biosciences from $63.00 to $66.00 and gave the company an "overweight" rating in a research report on Thursday.
IDEAYA Biosciences, Inc. stock logo
Twinbeech Capital LP Sells 71,664 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Twinbeech Capital LP lowered its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 44.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 87,802 shares of the company's stock after selling 71,664 sh
IDEAYA Biosciences, Inc. stock logo
Bank of America Corp DE Acquires 41,390 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Bank of America Corp DE lifted its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 5.9% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 747,934 shares of the company's stock after purchasing an additional 41,390 shares during the period. Bank
IDEAYA Biosciences, Inc. stock logo
Jane Street Group LLC Reduces Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Jane Street Group LLC trimmed its position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 30.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 54,934 shares of the company's stock afte
IDEAYA Biosciences, Inc. stock logo
Tema Etfs LLC Purchases New Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Tema Etfs LLC purchased a new stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 16,066 shares of the company's stock, valued
IDEAYA Biosciences, Inc. stock logo
D. E. Shaw & Co. Inc. Lowers Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
D. E. Shaw & Co. Inc. decreased its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 68.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 180,676 shares of the company's stock after selling 387,055 shares during the period. D.
IDEAYA Biosciences, Inc. stock logo
Polar Capital Holdings Plc Sells 589,500 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Polar Capital Holdings Plc lowered its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 90.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 65,500 shares of the company's stock after selling 589,500 shar
IDEAYA Biosciences, Inc. stock logo
Deutsche Bank AG Grows Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Deutsche Bank AG lifted its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 6.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 372,979 shares of the company's stock after purchasing
IDEAYA Biosciences, Inc. stock logo
MPM Bioimpact LLC Buys Shares of 414,035 IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
MPM Bioimpact LLC bought a new stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 414,035 shares of the company's stock, valued at approximately $10,641,
IDEAYA Biosciences, Inc. stock logo
Janus Henderson Group PLC Acquires 695,263 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Janus Henderson Group PLC increased its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 13.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,857,639 shares of the company's stock after acqui
IDEAYA Biosciences, Inc. stock logo
Ensign Peak Advisors Inc Cuts Stock Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Ensign Peak Advisors Inc reduced its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 7.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 564,217 shares of the company's stock after selling 47,597 shares during the peri
IDEAYA Biosciences, Inc. stock logo
The Manufacturers Life Insurance Company Sells 15,785 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
The Manufacturers Life Insurance Company lessened its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 16.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 82,602 shares of the
IDEAYA Biosciences, Inc. stock logo
FY2025 EPS Estimates for IDYA Cut by Cantor Fitzgerald
IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) - Investment analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for IDEAYA Biosciences in a report issued on Thursday, May 8th. Cantor Fitzgerald analyst L. Watsek now expects that the company will post earnings of ($2.62) per sh
IDEAYA Biosciences, Inc. stock logo
Dimensional Fund Advisors LP Has $8.91 Million Stock Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Dimensional Fund Advisors LP lowered its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 7.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 346,765 shares of the company's stock after selling 2
IDEAYA Biosciences, Inc. stock logo
16,769 Shares in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Acquired by Raymond James Financial Inc.
Raymond James Financial Inc. acquired a new stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 16,769 shares of the company's stock, valued at approxima
IDEAYA Biosciences, Inc. stock logo
Leerink Partnrs Has Positive Outlook of IDYA Q2 Earnings
IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) - Analysts at Leerink Partnrs increased their Q2 2025 earnings per share (EPS) estimates for shares of IDEAYA Biosciences in a research note issued to investors on Tuesday, May 6th. Leerink Partnrs analyst A. Berens now expects that the company
IDEAYA Biosciences, Inc. stock logo
Brokers Offer Predictions for IDYA Q2 Earnings
IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) - Wedbush issued their Q2 2025 earnings per share (EPS) estimates for IDEAYA Biosciences in a note issued to investors on Tuesday, May 6th. Wedbush analyst R. Driscoll expects that the company will post earnings of ($0.88) per share for the qua
IDEAYA Biosciences, Inc. stock logo
DAFNA Capital Management LLC Purchases 27,417 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
DAFNA Capital Management LLC grew its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 5.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 498,827 shares of the company's stock after purchasing an additional 27,417 shar
IDEAYA Biosciences, Inc. stock logo
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Purchased by Deerfield Management Company L.P. Series C
Deerfield Management Company L.P. Series C grew its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 5.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,736,000 shares of the company's stock
IDEAYA Biosciences, Inc. stock logo
Crestline Management LP Buys 70,571 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Crestline Management LP raised its position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 283.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 95,428 shares of the company's stock after acquiring an additi
IDEAYA Biosciences, Inc. stock logo
Brevan Howard Capital Management LP Increases Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Brevan Howard Capital Management LP increased its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 210.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,539 sh
IDEAYA Biosciences, Inc. stock logo
Axa S.A. Grows Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Axa S.A. grew its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 20.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 249,702 shares of the company's stock after buying an additional 41
IDEAYA Biosciences, Inc. stock logo
IDEAYA Biosciences (NASDAQ:IDYA) Announces Earnings Results
IDEAYA Biosciences (NASDAQ:IDYA - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.82) earnings per share for the quarter, missing the consensus estimate of ($0.75) by ($0.07). During the same quarter in the previous year, the company posted ($0.53) earnings per share.
IDEAYA Biosciences, Inc. stock logo
Voya Investment Management LLC Sells 281,664 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Voya Investment Management LLC decreased its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 84.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 52,313 shares of the company's stock after
IDEAYA Biosciences, Inc. stock logo
Avidity Partners Management LP Sells 246,300 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Avidity Partners Management LP decreased its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 17.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,126,700 shares of the company's stock after selling
IDEAYA Biosciences, Inc. stock logo
Hsbc Holdings PLC Raises Stock Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Hsbc Holdings PLC raised its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 66.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 38,690 shares of the company's stock after buying an ad
IDEAYA Biosciences, Inc. stock logo
Invesco Ltd. Has $1.46 Million Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Invesco Ltd. cut its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 63.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 56,691 shares of the company's stock after sellin
IDEAYA Biosciences, Inc. stock logo
Tower Research Capital LLC TRC Has $495,000 Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Tower Research Capital LLC TRC raised its position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 338.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 19,242 shares of t
IDEAYA Biosciences, Inc. stock logo
IDEAYA Biosciences (IDYA) Projected to Post Quarterly Earnings on Tuesday
IDEAYA Biosciences (NASDAQ:IDYA) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-ideaya-biosciences-inc-stock/)
IDEAYA Biosciences, Inc. stock logo
Aquatic Capital Management LLC Buys 29,189 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Aquatic Capital Management LLC lifted its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 47.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 91,189 shares of the co
IDEAYA Biosciences, Inc. stock logo
Price T Rowe Associates Inc. MD Lowers Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Price T Rowe Associates Inc. MD decreased its position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 3.7% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 3,866,908 shares of the company's stock after selling 148,390 shares during t
IDEAYA Biosciences, Inc. stock logo
Barclays PLC Boosts Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Barclays PLC lifted its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 9.7% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 198,756 shares of the company's stock after buying an additional 17,586 s
IDEAYA Biosciences, Inc. stock logo
Adage Capital Partners GP L.L.C. Has $30.84 Million Stock Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Adage Capital Partners GP L.L.C. boosted its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 22.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,200,094 shares of t
IDEAYA Biosciences, Inc. stock logo
Guggenheim Capital LLC Takes Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Guggenheim Capital LLC acquired a new stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 31,389 shares of the compan
IDEAYA Biosciences, Inc. stock logo
Marshall Wace LLP Buys 60,361 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Marshall Wace LLP raised its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 23.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 312,666 shares of the company's stock after acquiring
Get IDEAYA Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for IDYA and its competitors with MarketBeat's FREE daily newsletter.

IDYA Media Mentions By Week

IDYA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IDYA
News Sentiment

1.41

1.03

Average
Medical
News Sentiment

IDYA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IDYA Articles
This Week

12

6

IDYA Articles
Average Week

Get IDEAYA Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for IDYA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:IDYA) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners